The cost-effectiveness of metformin in the US diabetes prevention program trial: Simple interpretations need not apply

Based on previously published US Diabetes Prevention Program (DPP) cost-effectiveness analyses (CEAs) metformin continues to be promoted as "cost-effective." We review the DPP within-trial CEA to assess this claim. Treatment alternatives included placebo (plus standard lifestyle advice), b...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Preventive medicine 2024-01, Vol.178, p.107819-107819, Article 107819
Hauptverfasser:	Rittenhouse, Brian E, Alolayan, Sultan, Eguale, Tewodros, Segal, Alissa R, Doucette, Joanne
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!